Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
SEC Accession No. 0001104659-25-118930
Filing Date
2025-12-05
Accepted
2025-12-05 17:05:42
Documents
32

Document Format Files

Seq Description Document Type Size
1 F-4/A tm2528979d2_f4a.htm F-4/A 1939364
2 EXHIBIT 5.1 tm2528979d2_ex5-1.htm EX-5.1 14464
3 EXHIBIT 10.5 tm2528979d2_ex10-5.htm EX-10.5 100137
4 EXHIBIT 10.13 tm2528979d2_ex10-13.htm EX-10.13 30573
5 EXHIBIT 10.14 tm2528979d2_ex10-14.htm EX-10.14 29692
6 EXHIBIT 10.15 tm2528979d2_ex10-15.htm EX-10.15 31975
7 EXHIBIT 23.1 tm2528979d2_ex23-1.htm EX-23.1 3085
8 EXHIBIT 99.1 tm2528979d2_ex99-1.htm EX-99.1 8389
9 EX-FILING FEES tm2528979d2_ex-filingfees.htm   iXBRL EX-FILING FEES 29592
10 GRAPHIC annex_img001.jpg GRAPHIC 17624
11 GRAPHIC tm2528979d2_ex5-1img001.jpg GRAPHIC 3065
12 GRAPHIC tm2528979d2_ex99-1img001.jpg GRAPHIC 191530
13 GRAPHIC tm2528979d2_ex99-1img002.jpg GRAPHIC 127983
14 GRAPHIC tm2528979d2_f4aimg002.jpg GRAPHIC 198851
15 GRAPHIC tm2528979d2_f4aimg003.jpg GRAPHIC 78625
16 GRAPHIC tm2528979d2_f4aimg004.jpg GRAPHIC 106553
17 GRAPHIC tm2528979d2_f4aimg005.jpg GRAPHIC 87016
18 GRAPHIC tm2528979d2_f4aimg006.jpg GRAPHIC 53099
19 GRAPHIC tm2528979d2_f4aimg007.jpg GRAPHIC 162490
20 GRAPHIC tm2528979d2_f4asp4img01.jpg GRAPHIC 7043
21 GRAPHIC tm2528979d2_prosimg01.jpg GRAPHIC 4277
  Complete submission text file 0001104659-25-118930.txt   3736901

Data Files

Seq Description Document Type Size
34 EXTRACTED XBRL INSTANCE DOCUMENT tm2528979d2_ex-filingfees_htm.xml XML 7194
Mailing Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada
Business Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada 4036707377
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-4/A | Act: 33 | File No.: 333-290954 | Film No.: 251553745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)